Edwards Lifesciences Balance Sheet Health
Financial Health criteria checks 6/6
Edwards Lifesciences has a total shareholder equity of $7.2B and total debt of $597.2M, which brings its debt-to-equity ratio to 8.3%. Its total assets and total liabilities are $9.7B and $2.5B respectively. Edwards Lifesciences's EBIT is $1.8B making its interest coverage ratio -31.6. It has cash and short-term investments of $1.7B.
Key information
8.3%
Debt to equity ratio
US$597.20m
Debt
Interest coverage ratio | -31.6x |
Cash | US$1.70b |
Equity | US$7.19b |
Total liabilities | US$2.55b |
Total assets | US$9.74b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: EW *'s short term assets ($4.2B) exceed its short term liabilities ($1.1B).
Long Term Liabilities: EW *'s short term assets ($4.2B) exceed its long term liabilities ($1.4B).
Debt to Equity History and Analysis
Debt Level: EW * has more cash than its total debt.
Reducing Debt: EW *'s debt to equity ratio has reduced from 17.2% to 8.3% over the past 5 years.
Debt Coverage: EW *'s debt is well covered by operating cash flow (88.4%).
Interest Coverage: EW * earns more interest than it pays, so coverage of interest payments is not a concern.